US Stock MarketDetailed Quotes
BMY Bristol-Myers Squibb
- 59.940
- +0.720+1.22%
Close Dec 2 16:00 ET
- 60.018
- +0.078+0.13%
Post 16:13 ET
121.57BMarket Cap-16743P/E (TTM)
60.070High58.920Low8.86MVolume59.400Open59.220Pre Close527.96MTurnover0.44%Turnover Ratio15.53P/E (Static)2.03BShares61.08052wk High7.09P/B121.34BFloat Cap38.43652wk Low2.40Dividend TTM2.02BShs Float75.083Historical High4.00%Div YieldTTM1.94%Amplitude7.783Historical Low59.589Avg Price1Lot Size
About Bristol-Myers Squibb Company
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Company Profile
SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621
Websitehttp://www.bms.com
Company Executives
- Name
- Position
- Salary
- Dr. Christopher S. Boerner, PhD
- Chairman of the Board and Chief Executive Officer
- 8.46M
- Amanda Ahn Poole
- Executive Vice President and Chief Human Resources Officer
- --
- Adam Lenkowsky
- Executive Vice President and Chief Commercialization Officer
- --
- Dr. Samit Hirawat, M.D.
- Executive Vice President, Chief Medical Officer and Head of Development
- 6.23M
- Gregory Scott Meyers
- Executive Vice President, Chief Digital Officer and Chief Technology Officer
- --
- David V. Elkins
- Executive Vice President and Chief Financial Officer
- 7.17M
- Dr. Robert M. Plenge
- Executive Vice President, Chief Research Officer and Head of Research
- --
- Phil Holzer
- Senior Vice President and Controller
- --
- Sandra Leung
- Executive Vice President and General Counsel
- 5.92M
- Cari Gallman
- Executive Vice President, Corporate Affairs
- --
- Karin Shanahan
- Executive Vice President, Global Product Development and Supply
- --
- Lynelle Hoch
- President, Cell Therapy Organization
- --
- Michael R. McMullen
- Independent Director
- --
- Dr. Julia A. Haller, M.D.
- Independent Director
- 371.68K
- Dr. Deepak L. Bhatt, M.D.,M.P.H.
- Independent Director
- 329.97K
- Peter J. Arduini
- Independent Director
- 359.68K
- Dr. Karen H. Vousden, PhD
- Independent Director
- 344.74K
- Derica W. Rice
- Independent Director
- 375.00K
- Phyllis R. Yale
- Independent Director
- 365.00K
- Paula A. Price
- Independent Director
- 365.00K
- Theodore R. Samuels
- Lead Independent Director
- 425.00K
- Dr. Manuel Hidalgo Medina, M.D.,PhD
- Independent Director
- 335.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
